These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 31518202

  • 21. Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder.
    Chen HW, Bercik RS, Werner EF, Thung SF.
    J Urol; 2012 Jan; 187(1):178-84. PubMed ID: 22100006
    [Abstract] [Full Text] [Related]

  • 22. Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital.
    Dong A, Nabavizadeh R, Jiang JF, Washington SL, Master VA.
    J Health Care Poor Underserved; 2022 Jan; 33(3):1569-1582. PubMed ID: 36245181
    [Abstract] [Full Text] [Related]

  • 23. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN.
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [Abstract] [Full Text] [Related]

  • 24. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E.
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [Abstract] [Full Text] [Related]

  • 25. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO.
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [Abstract] [Full Text] [Related]

  • 26. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS, Abdulhamid AS, Ghaddaf AA, Alshareef KM, Haneef AK, AlQuhaibi MS, Banjar RA.
    Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
    [Abstract] [Full Text] [Related]

  • 27. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
    Zinkgraf K, Quinn AO, Ketterhagen D, Kreuziger B, Stevenson K.
    Urol Nurs; 2009 Oct; 29(1):30-4. PubMed ID: 19331273
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R, Yildiz N, Alkan H.
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [Abstract] [Full Text] [Related]

  • 29. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome.
    Kobashi K, Nitti V, Margolis E, Sand P, Siegel S, Khandwala S, Newman D, MacDiarmid SA, Kan F, Michaud E.
    Urology; 2019 Sep; 131():77-82. PubMed ID: 31199966
    [Abstract] [Full Text] [Related]

  • 30. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
    Finazzi-Agrò E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P.
    J Urol; 2010 Nov; 184(5):2001-6. PubMed ID: 20850833
    [Abstract] [Full Text] [Related]

  • 31. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis.
    Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K.
    Int Urogynecol J; 2020 Dec; 31(12):2457-2471. PubMed ID: 32681345
    [Abstract] [Full Text] [Related]

  • 32. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L, Renson C, Van de Walle J, Everaert K, Spinoit AF.
    Trials; 2021 Apr 02; 22(1):247. PubMed ID: 33810804
    [Abstract] [Full Text] [Related]

  • 33. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J, Connelly L, Dickson S, Duncan F, Lawrence M.
    Neurourol Urodyn; 2018 Feb 02; 37(2):528-541. PubMed ID: 28731583
    [Abstract] [Full Text] [Related]

  • 34. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.
    Martinson M, MacDiarmid S, Black E.
    J Urol; 2013 Jan 02; 189(1):210-6. PubMed ID: 23174264
    [Abstract] [Full Text] [Related]

  • 35. The effectiveness of different electrical nerve stimulation protocols for treating adults with non-neurogenic overactive bladder: a systematic review and meta-analysis.
    Zomkowski K, Kammers I, Back BBH, Moreira GM, Sonza A, Sacomori C, Sperandio FF.
    Int Urogynecol J; 2022 May 02; 33(5):1045-1058. PubMed ID: 35119495
    [Abstract] [Full Text] [Related]

  • 36. [Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes].
    Ohannessian A, Kaboré FA, Agostini A, Lenne Aurier K, Witjas T, Azulay JP, Karsenty G.
    Prog Urol; 2013 Sep 02; 23(11):936-9. PubMed ID: 24010924
    [Abstract] [Full Text] [Related]

  • 37. Factors Associated With Long-Term Use of Percutaneous Tibial Nerve Stimulation for Management of Overactive Bladder Syndrome.
    Gordon T, Merchant M, Ramm O, Patel M.
    Female Pelvic Med Reconstr Surg; 2021 Jul 01; 27(7):444-449. PubMed ID: 32649325
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A, Ghojazadeh M, Rahnama'I MS, Naseri A, Yazdandoost S, Khezerloo T, Seyedi-Sahebari S, Hosseinifard H, Vahed N, Mostafaei H, Salehi-Pourmehr H, Hajebrahimi S.
    Neurourol Urodyn; 2022 Feb 01; 41(2):539-551. PubMed ID: 35032328
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous tibial nerve stimulation in treatment of overactive bladder: when should retreatment be started?
    Marchal C, Herrera B, Antuña F, Saez F, Perez J, Castillo E, Cantero J, Milla F, Machuca J, Redondo M, Galacho A.
    Urology; 2011 Nov 01; 78(5):1046-50. PubMed ID: 21908024
    [Abstract] [Full Text] [Related]

  • 40. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
    Boudaoud N, Binet A, Line A, Chaouadi D, Jolly C, Fiquet CF, Ripert T, Merol ML.
    J Pediatr Urol; 2015 Jun 01; 11(3):138.e1-10. PubMed ID: 25979217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.